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Paul J. Yaworsky1 and Claudia Kappen2
Molecular Neuroscience Program, Samuel C. Johnson Medical Research Center,
Mayo Clinic Scottsdale, Scottsdale, Arizona 85259
Using transgenic embryos, we have identified two distinct CNS progenitor cell-specific enhancers, each requiring the
cooperation of at least two independent regulatory sites, within the second intron of the rat nestin gene. One enhancer is
active throughout the developing CNS, while the other is specifically active in the ventral midbrain. These experiments
demonstrate that neural progenitor cells in the midbrain constitute a unique subpopulation based upon their ability to
activate the midbrain regulatory element. Our finding of differential enhancer activity from a gene encoding a structural
protein reveals a previously unrecognized diversity in neural progenitor cell populations. © 1999 Academic Press
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eINTRODUCTION
In the developing nervous system, multipotential stem
cells give rise to neurons and glia (reviewed in McKay, 1997;
Morrison et al., 1997; Stemple and Mahanthappa, 1997). An
arly marker for most, but not all, stem cells in the central
ervous system (CNS) is the intermediate filament protein,
estin (Dahlstrand et al., 1995; Frederiksen and McKay,
988; Hockfield and McKay, 1985; Lendahl et al., 1990;
eynolds and Weiss, 1992; Williams and Price, 1995). Upon
euronal differentiation, a switch in intermediate filament
ene expression replaces nestin with the neurofilaments
Lendahl et al., 1990; reviewed in Lee and Cleveland, 1996).
n the adult CNS, nestin is reexpressed in reactive astro-
ytes (Clarke et al., 1994; Frise´n et al., 1995) and in CNS
neuroepithelial tumors, most notably, gliomas and glioblas-
tomas (Dahlstrand et al., 1992a; Tohyama et al., 1992).
During embryonic development, nestin expression is not
restricted to the CNS. Nestin is also found in myogenic
precursors (Kachinsky et al., 1994; Lendahl et al., 1990;
ejersen and Lendahl, 1993), the peripheral nervous system
Dahlstrand et al., 1995; Hockfield and McKay, 1985;
temple and Anderson, 1992), the heart (Kachinsky et al.,
1 Current address: Genetics Institute, Inc., 87 Cambridge Park
Drive, Cambridge, MA 02140.
2 To whom correspondence should be addressed at Samuel C.
ohnson Medical Research Center, Mayo Clinic Scottsdale, 13400
. Shea Boulevard, Scottsdale, AZ 85259. Fax: (602) 301-7017.t-mail: kappen@mayo.edu.
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All rights of reproduction in any form reserved.995), the developing tooth bud (Terling et al., 1995), and
he testis (Fro¨jdman et al., 1997).
The regulation of nestin gene expression during develop-
ent has been investigated recently in transgenic mice
Zimmerman et al., 1994). Interestingly, the upstream pro-
oter region of the gene does not possess any regulatory
lements specific for neural stem cells. Instead, this work
dentified a myogenic precursor cell-specific enhancer
ithin the first intron and a CNS-specific enhancer within
he second intron of the rat nestin gene. This second intron
rom the nestin gene has since been used to direct heterol-
gous gene expression to the developing nervous system
Lardelli et al., 1996; Lothian and Lendahl, 1997; Ringstedt
t al., 1997).
To understand more about the molecular mechanisms
hat direct gene expression to neurons and their progenitor
ells during development, we constructed a comprehensive
et of overlapping deletions within the 1.8-kb second intron
f the rat nestin gene. By monitoring the expression of a
acZ reporter gene in transgenic embryos, we have tested
arious DNA fragments for enhancer activity. Based on the
volutionary conservation of the nestin gene (Dahlstrand et
l., 1992b), we also cloned the second intron from the
uman nestin gene and demonstrated that it contained
nhancer activity specifically in neuroepithelial cells. Our
esults define DNA regulatory elements that control spatial
nd temporal regulation of nestin enhancer activity during
mbryonic development. In addition, we provide evidence
hat neuroepithelial cells differ in their ability to activate
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310 Yaworsky and Kappendistinct enhancers. The transcriptional diversity of precur-
sor cells in the developing nervous system implies a previ-
ously unrecognized heterogeneity. Our finding of discrete
enhancer elements now allows for the identification of the
respective regulatory transcription factors which establish
heterogeneity in neural progenitor cells. Furthermore, these
regulatory elements will be valuable tools to introduce
heterologous gene expression to neurons and their precur-
sor cells.
MATERIALS AND METHODS
Constructs
pLacZ. A 4.0-kb EcoRI/XhoI fragment containing the LacZ
gene linked to 142 bp of the promoter from the immediate early (IE)
gene ICP4 of herpes simplex virus (Yaworsky et al., 1997) was
end-filled and ligated into an EcoRV opened pSafyre vector (Boga-
rad, unpublished data). This minimal IE-promoter–LacZ construct
was used to generate all of the subsequent plasmids.
Construct 1. A 1.85-kb BstYI fragment from the plasmid pNe-
sIx (kind gift of Dr. A. McMahon, Harvard University) correspond-
ing to the second intron of the rat nestin gene (Zimmerman et al.,
1994) was ligated into the BamHI site of pLacZ. The forward
orientation of the insert was confirmed by restriction mapping.
Constructs 2–19. Deletions within the second intron of the rat
nestin gene were generated either by restriction endonuclease
digestion or by the polymerase chain reaction (PCR). In cases where
PCR was used, primers were designed to each contain 16 oligonu-
cleotides of nestin intron sequence. To facilitate directional clon-
ing into the pLacZ plasmid, the PCR primers incorporated restric-
tion enzyme sites. The 59 primers all contained an XbaI site while
the 39 primers had a PstI site. All primers contained two random
bases at the 59 end for optimal restriction digest of the amplified
product. Identical PCR conditions of 28 cycles of 94°C for 30 s,
62°C for 1 min, 72°C for 30 s with 94°C for 5 min at the first cycle,
and 72°C for 5 min at the last cycle were used. Each clone generated
by PCR was sequenced to ensure identity to the wild-type se-
quence. The beginning and end base positions of each deletion
fragment are indicated in Fig. 1. The numbering exactly coincides
with our GenBank submission (Accession No. AF004334).
Construct 20. Cloning the second intron from the human
nestin gene. The second intron from the human nestin gene was
amplified from human genomic DNA by PCR using primers
59-AATCTAGACCTGGAGGTGGCCAACG-39 and 59-AACTGC-
AGAGTTCTCAGCCTCCAGG-39 which anneal in the coding
region of the human nestin gene flanking the second intron
(Dahlstrand et al., 1992b) and provide XbaI and PstI restriction
sites. Cycling conditions were at 94°C, 30 s; 60°C, 1 min; 72°C, 1
min for 35 cycles with a 5-min initial denaturation step at 94°C and
a final 5-min extension at 72°C. A 1.73-kb amplification product
was agarose gel purified (Qiagen, Chatsworth, CA) and cloned into
the pCRScript vector (Stratagene, La Jolla, CA). The plasmid,
pHNes, was digested with XbaI and PstI, which generated a short
deletion from the 39-end of the intron, and ligated into pLacZ
creating Construct 20. This plasmid contains 1605 bp of the second
intron from the human nestin gene.
DNA Sequence Analysis
The 1.85-kb BstYI fragment from the plasmid pNesIx and the1.73-kb fragment of pHNes were used to sequence the second e
Copyright © 1999 by Academic Press. All rightintron from the rat and human nestin genes, respectively. Auto-
mated DNA sequencing was performed on an Applied Biosystems
373A DNA Sequencer (ABI, Foster City, CA). Primers were specifi-
cally designed to provide sequence from both DNA strands. Sub-
sequent sequence analyses were carried out using the University of
Wisconsin Genetics Computer Group (Madison, WI) software or
McMolly Tetra (Soft Gene GmbH, Berlin).
Generation and Identification of Transgenic
Embryos
DNA fragments of interest were isolated by agarose gel electro-
phoresis and purified over Qiagen columns. The purified DNA was
diluted to a final concentration of 2.0 mg/ml in a buffer of 10 mM
ris–Cl, pH 7.3, 0.25 mM EDTA for microinjection. FVB mice were
sed as donors for microinjection and CD-1 mice were used as foster
others following standard protocols of Hogan et al. (1994). The yolk
ac of each embryo was used as a source of genomic DNA and the
resence of the LacZ transgene was detected by PCR. Using the
rimers 59-GACGGGTTGTTACTCGCTCAC-39 and 59-GCGTGT-
ACCACAGCGGATGGT-39, an 868-bp amplification product identi-
fies the LacZ transgene after 35 cycles of 94°C for 30 s, 62°C for 1 min,
72°C for 30 s with an initial denaturation step of 94°C for 5 min, and
a final extension step of 72°C for 5 min.
Embryo Isolation and b-Galactosidase Staining
Embryos were isolated at various developmental stages with the
morning of the microinjection designated as 0.5 dpc. Embryos were
fixed in 4% paraformaldehyde in PBS at 4°C for 2 h at 10.5 dpc and
for 3 h at 13.5 dpc. The fixative was removed with three washes of
15 min at 37°C in a buffer of 100 mM NaH2PO4, pH 7.3, 2 mM
gCl2, 0.1% deoxycholate, 0.2% NP-40. Staining proceeded in the
ame buffer supplemented with 5 mM K3Fe(CN)6 z 3H2O, 5 mM
K4Fe(CN)6 and 1 mg/ml X-gal. Staining was monitored after 1 h and
allowed to proceed overnight. The reaction was stopped by rinsing
with PBS and postfixing the embryos in 4% paraformaldehyde/
0.25% glutaraldehyde in PBS for 4 h at 4°C. Embryos were
dehydrated in 70% ethanol and photographed on a Leica Stereo
Zoom M3Z microscope. Histologic sections were obtained by
embedding the embryos in paraffin and microtome sectioning at
10-mm thickness. Sections were analyzed and photographed with a
Leica DMRB microscope.
Immunohistochemistry on Tissue Sections
Embryos were isolated at 10.5 dpc in ice-cold PBS, fixed for 3 h
in 4% paraformaldehyde in PBS, embedded in paraffin wax, and
microtome cross-sectioned at a thickness of 10 mm. Immunohis-
tochemical staining was carried out using the Vectastain Elite ABC
Kit and Vector DAB Substrate Kit (Vector Laboratories, Burlin-
game, CA). The anti-rat-nestin (Clone Rat-401, PharMingen, San
Diego, CA) primary antibody was used at a concentration of 5
mg/ml; the anti-proliferating-cell nuclear antigen (Clone PC10,
Boehringer Mannheim, Indianapolis, IN) was used at 50 mg/ml. No
staining was observed in the absence of primary antibody. The
sections were counterstained briefly with hematoxylin and photo-
graphed on a Leica DMRB microscope.
Statistical Analysis
Statistical independence was established using the x2 test. In
ases where any expected frequency was less than 5, the Fisher
xact test was used.
s of reproduction in any form reserved.
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311CNS Enhancer Elements in the Nestin GeneRESULTS
The Nestin CNS Stem Cell Enhancer Resides in the
3* Region of the Second Intron
Zimmerman et al. (1994) have previously demon-
strated that the second intron of the rat nestin gene
contains CNS stem cell enhancer activity. A 1.85-kb
DNA fragment, containing the full 1670 bp of the second
intron, was shown to direct LacZ expression exclusively
within the developing CNS of transgenic embryos. To
identify which genetic regulatory elements conferred this
neuroepithelial expression pattern, we generated dele-
tions of the nestin intron and assayed for enhancer
activity using a heterologous promoter. Figure 1 depicts
the various deletion constructs tested, each construct’s
tissue specificity, and the identification of several regu-
latory elements within the enhancer as indicated by
colored triangles. Using a minimal promoter from the
herpes simplex virus ICP4 gene with the full 1.85-kb
nestin intron fragment, construct 1 (Fig. 1), we were able
to reproduce the staining pattern previously observed at
10.5 days postcoitum (dpc) (Zimmerman et al., 1994) (Fig.
2A). Intense b-galactosidase activity was detected in the
elencephalon, diencephalon, mesencephalon, meten-
ephalon, myelencephalon, and spinal cord. Ventral spi-
al cord staining progressed along the entire anterior–
osterior axis of the embryo except at the most posterior
ortions of the spinal cord. Dorsal regions of the telen-
ephalon did not stain, and in the spinal cord, dorsal
taining was found only in regions anterior to the fore-
imb buds.
Deletions of the nestin intron revealed that the CNS-
pecific enhancer(s) reside(s) downstream of base 1069.
ransgenic embryos which expressed construct 4 dis-
layed a pattern of staining identical to that observed
ith the full 1.85-kb intron fragment (compare Figs. 2A
nd 2B). As we observed with construct 1, b-galactosidase
staining was slightly reduced in the most posterior por-
tion of the ventral spinal cord. In addition, staining in the
dorsal spinal cord was weak, even at anterior levels. In
the developing brain, staining was restricted by bound-
aries between the telencephalon and the diencephalon
and between the mesencephalon and the metencephalon.
The staining pattern from construct 3 was identical to
that of both constructs 1 and 4 (not shown). Construct 2,
which lacked the 39 portion of the intron, could not direct
LacZ expression in the developing CNS (not shown).
These results restrict any relevant enhancers to the
interval between bases 1069 and 1850, in the 39 region of
he intron. Constructs 5 and 6, which contained shorter
9 regions of the intron, were unable to produce LacZ
ransgene expression within the developing nervous sys-
em (Fig. 2C). These data suggested that the relevant CNS
nhancer elements reside within the 332-bp region be-
ween bases 1069 and 1401.
Copyright © 1999 by Academic Press. All rightIdentification of a Midbrain-Specific Enhancer
Constructs 7 and 8 contained the intron fragment be-
tween bases 1068 and 1406 in forward and reverse orienta-
tion, respectively. Unexpectedly, these constructs did not
reproduce the full staining pattern but rather contained
enhancer activity specific for the developing midbrain (Fig.
2D). Only cells of the mesencephalon expressed the trans-
gene with a concentration of staining localized in more
ventral regions (Fig. 2D). Regardless of enhancer orienta-
tion, identical b-galactosidase expression patterns were
observed, confirming that the midbrain-specific element
functions as a true enhancer (not shown). To further local-
ize the midbrain-specific element, we analyzed five addi-
tional constructs that overlap this 339-bp fragment. Con-
structs 9 and 10 represent the last and first two-thirds of the
339-bp midbrain enhancer element, respectively. Construct
9 was unable to specifically direct transgene expression to
the nervous system (not shown). However, construct 10
produced LacZ transgene expression in the developing
mesencephalon, narrowing the relevant DNA region down
to 204 bp (Fig. 2E). The dorsal extension of stained cells
along the midbrain–hindbrain border previously observed
in the construct 8 embryo (Fig. 2D) was not seen in every
midbrain-stained embryo (compare with Fig. 2E), possibly
due to variability in developmental maturity. In fact, 3 of a
total of 16 embryos with midbrain staining (constructs 7, 8,
10, and 11, combined Fig. 1) displayed the pattern shown in
Fig. 2E, while 13 exhibited staining in more dorsal cells
corresponding the the pattern in Fig. 2D. Attempts to
further shorten the enhancer proved inconclusive. With
construct 11, we observed 3 of 43 transgenic embryos that
exhibited a midbrain expression pattern (Fig. 2F), with an
additional 7 transgenic embryos displaying independent
and different ectopic staining (not shown). This low fre-
quency of specific staining (7.0%) compared with the fre-
quency of midbrain-specific staining observed with con-
structs 7, 8, and 10 combined (38%), suggested that either
the midbrain enhancer did not reside on this fragment or
that the 123-bp enhancer was too weak to overcome DNA
integration effects in the transgenic embryos. Alternatively,
the spacing of the enhancer relative to the minimal pro-
moter could have been suboptimal to allow consistent
expression of enhancer activity. To test the latter possibil-
ity, we generated a construct with 3 copies of this 123-bp
DNA fragment, construct 12, that would place the en-
hancer at varying distances from the transcription start site.
None of the 4 transgenic embryos obtained with this
multimerized fragment displayed specific staining in the
midbrain (not shown). To formally exclude that the
midbrain-specific enhancer might reside between bases
1190 and 1199 (difference between constructs 9 and 11), we
generated construct 13. No midbrain-enhancer activity was
observed in these transgenic embryos (not shown). There-
fore, we concluded that the midbrain-specific enhancer
resides between bases 1068 and 1271 as positively demon-
strated with construct 10 (Fig. 2E).
s of reproduction in any form reserved.
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313CNS Enhancer Elements in the Nestin GeneFIG. 2. Whole mount b-galactosidase activity in transient transgenic embryos. Embryos were isolated at 10.5 dpc and assayed for
b-galactosidase activity. Reprentative embryos are depicted for A, construct 1; B, construct 4; C, construct 5; D, construct 8; E, construct
10; F, construct 11; G, construct 15; H, construct 19; I, construct 20. Consistently, three staining patterns emerged: the entire developing
CNS was positive (A, B, G–I), or ventral midbrain only (D–F), or the neuroepithelium was negative (C).FIG. 1. Nestin enhancer deletion constructs and LacZ transgene expression results. The LacZ gene is linked to the minimal IE gene
romoter and is represented schematically as an open box; the solid dark line indicates the nestin enhancer. Numbering for the 1.85-kb
stYI fragment from plasmid pNesIx (for constructs 1–19) and for the 1.73-kb PCR product cloned in plasmid pHNes (for construct 20) is
dentical to the sequence entries in GenBank under Accession Nos. AF004334 (rat) and AF004335 (human). Four DNA regulatory elements
ave been identified and are indicated with colored triangles: midbrain-specific element, blue; general transcriptional potentiator, yellow;
NS element I, green; CNS element II, red. All enhancer fragments are in the 59–39 orientation unless indicated otherwise by an arrow
constructs 8 and 12). The number of embryos isolated and examined for enhancer activity at 10.5 dpc is indicated; the transgene-positive
olumn shows how many of these embryos carried the LacZ transgene, as determined by PCR screening of yolk sac DNA. Central nervous
ystem b-galactosidase activity was divided into two categories: either the full CNS stained (marked under the column “entire”) or only
ells of the midbrain stained (under the column MB). Embryos which stained outside of the nervous system were scored as ectopic. The
sterisk under the MB column with construct 12 indicates that although the midbrain stained in one embryo, staining was also present at
onspecific sites such as the heart, limbs, skin, and additional neural tissue and was therefore scored as ectopic.
Copyright © 1999 by Academic Press. All rights of reproduction in any form reserved.
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314 Yaworsky and KappenA Transcriptional Potentiator Element Is
Necessary for Midbrain-Specific Enhancer Activity
The large number of transgenic embryos produced in this
study allowed us to perform statistical analyses on en-
hancer activity. These results suggested the presence of a
general transcriptional potentiator element which is neces-
sary for efficient activity of the midbrain-specific enhancer.
In the case of construct 9 (bases 1200–1406), we observed
that 5 of 16 (31%) transgenic embryos exhibited intense
b-galactosidase activity at ectopic sites in completely inde-
pendent staining patterns (not shown). This high frequency
of ectopic staining (31% compared to 7%, 16 of 222, for all
other constructs combined, P 5 0.008) was suggestive of the
presence of an element that alone possesses no tissue
specificity, but that enables transcriptional activity when
under the influence of another enhancer. We propose that
this transcriptional potentiator resides between bases 1200
and 1271 based on the ratio of the number of LacZ-
expressing embryos (specific or ectopic) to the total number
of transgenic embryos. Reproducible midbrain-specific en-
hancer activity was detectable only with constructs (con-
structs 7–10) that harbored the putative transcriptional
potentiator element (Fig. 1). A further refinement of this
element between bases 1200 and 1255 was based on con-
structs 7–19. Constructs 7–10, all of which contained bases
1200–1271, yielded 20 of 50 embryos (40%) that had spe-
cific or ectopic LacZ expression. Furthermore, constructs
4–16, also containing bases 1200–1255, produced 15 of 20
75%) LacZ-expressing embryos. In contrast, constructs
hich lacked bases 1200–1271 produced low numbers of
mbryos with b-galactosidase activity. Constructs 11–13
enerated only 15 of 69 (22%), P 5 0.031) stained embryos
hile constructs 17–19 yielded 10 of 39 (26%, P 5 0.0003)
tained embryos. While these observations did not conclu-
ively prove the existence of such an element, the statisti-
al analyses of LacZ expression (see also legend to Table 1)
upport the presence of the putative potentiator element
etween bases 1200 and 1255. Taken together, our results
emonstrated that tissue-specific enhancer activity in the
idbrain was achieved through the interaction/cooperation
f a midbrain-specifying element, element A (between 1068
nd 1199, blue triangle) and a transcriptional potentiator,
lement B (between 1200 and 1255, yellow triangle).
Mapping of Elements Required for Enhancer
Activity in the Entire CNS
The identification of a midbrain-specific enhancer be-
tween bases 1068 and 1271 led us to postulate that at least
one other region in the nestin intron would have to be
responsible for the CNS staining pattern observed with
construct 4 (Fig. 2B). Furthermore, we reasoned that such
element(s) must be located between bases 1401 and 1850
since we observed the original CNS activity with construct
4 (Fig. 2B), yet constructs 7 and 8 were only active in the
midbrain (Fig. 2D). In addition, constructs 5 and 6 showed
Copyright © 1999 by Academic Press. All righthat the most 39 region of the nestin intron alone (bases
406–1850) was unable to function as an enhancer (Fig. 2C).
hus, CNS activity in regions beyond the midbrain would
ither require an element in the region around 1401–1406
hich would be split in constructs 5 and 7–9, or the
nteraction of sequences in the 1068–1406 fragment with
hose in the 1406–1850 fragment. To identify the elements
esponsible for this interaction, we generated deletions
rom the 39 end of the intron. Two independent constructs,
4 and 15, produced staining patterns that were identical to
ach other as well as indistinguishable from those obtained
rom construct 4 (Fig. 2G). These results suggested that the
egulatory element(s) contributing to spinal cord and brain-
pecific enhancer activity must reside were encompassed
etween bases 1068 and 1587.
We then asked if the midbrain enhancer (1068–1271) was
equired for the full CNS pattern, and generated three
dditional deletions from the 59 end through the midbrain
nhancer. Constructs 16, 17, and 18 were all able to
eproducibly generate the expression pattern observed with
onstruct 4 (not shown). Furthermore, construct 18 demon-
trated that the CNS enhancer activity was achieved in the
bsence of the midbrain enhancer. Subsequent deletion
rom the 39 end to base 1477 in construct 19 indicated that
206-bp enhancer fragment could reproducibly generate the
ull nestin intron staining pattern (Fig. 2H). From these
esults, we concluded that (a) regulatory element(s) within
hose 206 bp is/are sufficient for CNS enhancer activity.
hile we cannot formally exclude the presence of a single
lement that overlaps with the bases around 1401–1406, we
avor the interpretation that elements between bases 1272
nd 1400 interact with elements between bases 1401 and
587 to produce the original pattern of gene expression
bserved with the intact intron. This proposition is sup-
orted by the presence of putative binding sites in the
espective sequences (see below, Fig. 4). The above results
efined the location of the two cooperating elements in the
NS enhancer to element C (between bases 1272 and 1400,
reen triangles in Fig. 1) and to element D (between bases
401 and 1477, red triangles in Fig. 1). The addition of
lement B to the 206-bp CNS enhancer (construct 16)
esulted in a high frequency of transcriptionally active
ransgenes, further supporting a role for element B as a
ranscriptional potentiator.
The Second Intron of the Human Nestin Gene
Possesses CNS-Specific Enhancer Activity
Based on the high degree of conservation between the
rat and human nestin gene (Dahlstrand et al., 1992b), we
presumed that the human nestin gene would possess
similar neural enhancers within its second intron. There-
fore, we cloned the second intron from the human nestin
gene and assayed for enhancer activity in transgenic
embryos. The 1.7-kb human clone contained 21 bp of
exon 2, the complete 1687 bp of intron 2, and 23 bp of
exon 3. Based on our mapping of enhancers in the rat
s of reproduction in any form reserved.
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first 1584 bp of human intron sequence (Fig. 1). Five
of seven transgenic embryos exhibited intense
FIG. 3. Cellular localization of nestin enhancer activity and ne
obtained from either LacZ-stained transgenic embryos (A–I) or fro
of a 10.5 dpc embryo showing the sectioning planes is presented in
the right. A–C, construct 1; D, construct 4; E, construct 8; F and G
for nestin. In the developing brain, b-galactosidase activity is detect
idbrain cells were targeted with construct 8 (E). Midbrain cells a
nhancer activity is observed in both ventral and dorsal cells with
entrally restricted in posterior spinal cord (C, I). Nestin immunor
osterior spinal cord (K), except in areas where presumptive motor
etected in notochord, dorsal root ganglia, and endothelial walls of b
ctivity (I) or by nestin protein detection (K).b-galactosidase staining throughout the entire CNS (Fig. t
Copyright © 1999 by Academic Press. All rightI). The expression pattern was similar to that previously
bserved with the rat enhancer with construct 1, 4, or 19
Figs. 2A, 2B, and 2H). These experiments demonstrated
immunoreactivity. Histologic cross and transverse sections were
rmal control embryos (J, K) at a thickness of 10 mm. A schematic
idbrain, m; hindbrain, h; notochord, n; floor plate, fp. Dorsal is to
struct 19; H and I, construct 20; J and K, immunohistochemistry
stripes in both the midbrain and hindbrain (A, D, F); however, only
dicated with a white arrow (A, D–F, J). In the anterior spinal cord,
ng ventricular cell localization (B, G, H). Staining becomes more
vity is uniform throughout the hindbrain and midbrain (J) and the
rons have differentiated (black arrow). Immunoreactivity was also
vessels. Some axonal projections were detected by either enhancerstin
m no
L. M
, con
ed in
re in
stro
eacti
neu
loodhat the second intron from the human nestin gene also
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tional conservation of these intronic enhancer elements
during evolution.
Activity of the Nestin Enhancers Follows Strict
Boundaries within the Neuroepithelium
To characterize the specific neuroepithelial cells tar-
geted by the midbrain and CNS enhancers, we examined
histologic sections from transgenic embryos. Sections
through a construct 1 embryo confirmed that all of the
b-galactosidase activity was restricted to cells of the
eveloping nervous system. In the hindbrain, an intense
entrally localized stripe of expression was visible
round the fourth ventricle (Fig. 3A). Staining was also
bserved in lateral stripes around the third ventricle of
he ventral midbrain. The anterior spinal cord of these
mbryos showed b-galactosidase activity in both ventral
nd dorsal cells; however, the dorsalmost regions of the
pinal cord were consistently negative (Fig 3B). The
taining in ventral regions was intense and predomi-
antly localized to ventricular cells with activity de-
ected along the pial surface as well. Floor plate cells and
he notochord did not stain. In the more posterior region
f the spinal cord, the staining became more restricted to
entral, ventricular cells (Fig 3C).
The cellular localization of b-galactosidase activity was
identical between constructs 1 and 4 (compare Figs. 3A and
3D). However, sections through construct 8 embryos con-
firmed that only ventral cells of the midbrain were stained
(Fig. 3E). Positive cells were present bilaterally, on each side
of the third ventricle, in tegmental neuroepithelial cells. In
contrast, construct 19, which contained the 206-bp CNS
enhancer, produced stripes of staining in both the hindbrain
and midbrain similar to the original expression pattern
observed with constructs 1 and 4 (compare Figs. 3A, 3D, and
3F). Staining in the anterior spinal cord was also similar,
although the intensity of staining was weak dorsally (Fig.
3G). These experiments showed that the 206-bp CNS en-
hancer contained all of the spatial and temporal regulatory
elements necessary for the full (construct 1) enhancer
expression pattern. The human nestin enhancer was the
strongest enhancer used in this study. Sections through the
anterior spinal cord of these embryos displayed intense
b-galactosidase activity throughout the entire dorsal–
ventral axis of the spinal cord (Fig. 3H). The notochord and
floor plate cells again appeared negative. The posterior
spinal cord of these embryos was strongly stained; however,
as we observed with previous constructs, the dorsalmost
region of the spinal cord was only weakly positive (Fig. 3I).
Together these data revealed that only cells in the develop-
ing nervous system were targeted by either nestin enhancer;
yet, it is important to note that not every neuroepithelial
cell activated the nestin enhancers at this developmental
stage.
Copyright © 1999 by Academic Press. All rightHeterogeneity of Neuronal Progenitors Revealed by
Nestin Enhancer Activity
Using a monoclonal antibody against nestin, we com-
pared nestin protein expression to nestin enhancer activity.
While expression from the nestin enhancers observed strict
boundaries (Figs. 3A–3I), nestin immunoreactivity was de-
tected throughout the entire dorsal–ventral axis (Fig. 3J) in
the hindbrain and midbrain. In the spinal cord, nestin
expression was detected both in ventral and dorsal cells
(Fig. 3K); however, as reported previously (Frederiksen and
McKay, 1988; Zimmerman et al., 1994), it was absent in
postmitotic regions of the ventral horns where presumptive
motor neurons are differentiating (black arrow, Fig. 3K).
Interestingly, the notochord was weakly immunopositive
and yet none of the enhancer constructs were active there.
The more extensive expression of nestin protein indicated
that additional DNA regulatory elements, residing outside
of the second intron, possibly participate in the regulation
of the endogenous nestin gene locus. The comparison of
protein expression and enhancer activity at 10.5 dpc sug-
gested that cells in the neuroepithelium could be subdi-
vided into at least three populations: nestin-positive cells
that activate the midbrain-specific enhancer, nestin-
positive cells that activate the CNS-specific enhancer, and
nestin-positive cells that do not activate either enhancer.
This was most apparent when Figs. 3A and 3D–3F were
compared with Fig. 3E. Constructs 1, 4, 8, and 19 targeted
midbrain tegmental neuroepithelial cells in the very same
location (indicated with a white arrow). Although the
enhancer from construct 8 was activated by cells in the
midbrain, other CNS cells were unable to activate this
fragment. This observation suggested that these ventral
midbrain precursor cells are different from other CNS
progenitor cells, such as in the spinal cord and forebrain.
Similarly, within the spinal cord, ventral cells expressed the
LacZ transgene when presented with the CNS enhancer,
while dorsal cells did not. Thus, neuroepithelial cell popu-
lations differ in their capability to activate different nestin
enhancer elements at a given time point. These data pro-
vide molecular evidence that neural progenitor cells are
heterogeneous based on differences in their transcription
factor repertoires. Thus, the isolation of nestin enhancer
elements in transgenic mice reveals a molecular heteroge-
neity in neural progenitor cells that is not apparent with
either in situ hybridization or immunohistochemical ap-
proaches.
Temporal Regulation of Nestin Enhancers
To further analyze the specificity of our novel midbrain-
enhancer element (construct 8), we characterized the activ-
ity of this enhancer during embryogenesis. The midbrain
enhancer was only active at 10.5 dpc (Table 1) but not at
later developmental stages as evidenced by b-galactosidase
activity. These data suggested that the midbrain neuroepi-
thelial cells that expressed the transgene at 10.5 dpc are a
unique subpopulation of neuroepithelial cells that possess a
s of reproduction in any form reserved.
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317CNS Enhancer Elements in the Nestin Genedistinct complement of transcription factors. Such molecu-
lar differences enable transient enhancer activity in these
specific cells for a short period of time prior to terminal
neuronal differentiation. In contrast, activity from the CNS
enhancer, as represented with either construct 16 or the
human enhancer (construct 20), was maintained in CNS
progenitor cells at later developmental stages (Table 1).
Sequence Comparison of the Rat and Human
Nestin Enhancers
In parallel to our functional analyses in transgenic mice,
we sequenced the second intron of both the rat and human
nestin genes. We expected that DNA sequences of func-
tional enhancer elements would be conserved between rat
and human. The rat intron contained 1670 bp, while the
human had 1687 bp. Both sequences were novel and had no
overall similarities to sequences in the databases. A com-
parison between the two sequences revealed a highly diver-
gent 59 region and a clustering of conserved regions in the 39
end of the intron, resulting in 37% total similarity (Fig. 4A).
The stretches of sequence conservation exactly coincided
with regions of the intron for which we have demonstrated
neural enhancer activity. The 204-bp midbrain enhancer is
72% identical between rat and human (Fig. 4B), while the
206-bp CNS enhancer is 85% identical (Fig. 4C). Few
consensus sequences for putative transcription factor bind-
ing were present in either enhancer region. Two putative
retinoid-X receptor b (RXR-b) half-site consensus sequences
TABLE 1
Temporal Regulation of Nestin Enhancer Activity
Construct
Stage
(dpc)
Number of
embryos
8 (midbrain enhancer) 9.5 7
10.5 73
11.5 34
12.5 37
13.5 126
16 (CNS enhancer) 10.5 43
13.5 69
17.5 32
20 (human) 10.5 21
13.5 33
Note. Embryos generated with the midbrain enhancer (constru
solated at various developmental stages and assayed for b-galactos
f LacZ-transgene-positive embryos (as detected by PCR) are presen
0.5 days. Both constructs 16 and 20 maintain neuroepithelial-spe
ctopically stained embryos from construct 8 at later developm
ranscriptional potentiator in this fragment. In the absence of activ
ctivity), an increased frequency of transcriptional activity at ectop
otal transgenics (41%) compared to 21 of 2597 (8%) for all other c(Marks et al., 1992) were conserved: in the midbrain en-
Copyright © 1999 by Academic Press. All righthancer at base 1154 of the rat (base 1029 in human), and in
the CNS-enhancer at base 1469 in the rat (1373 in human).
In addition, the CNS enhancer had two putative POU–
domain transcription factor binding sites which were con-
served in both species: a Pit-1 binding site (Peers et al.,
1990) at base 1292 in rat (1187 in human) and a POU-class
III binding site (Li et al., 1993) at base 1435 in rat (1339 in
uman). This high degree of sequence similarity and the
onservation of putative transcription factor binding sites
n regions shown to possess enhancer activity suggested
hat similar regulatory mechanisms may control nestin
xpression in both rat and human.
DISCUSSION
To understand the molecular mechanisms regulating
gene expression in neuroepithelial cells, we localized regu-
latory sequences in the rat nestin gene that control neuro-
nal enhancer activity. Our results demonstrate that two
separable enhancer elements reside within the second in-
tron of the gene. We have identified a 204-bp midbrain-
specific enhancer between bases 1068 and 1271, and a
206-bp CNS enhancer between bases 1272 and 1477. We
show that these two enhancers can function independently
of each other and that they each require the cooperation of
at least two distinct regulatory sites. In the midbrain en-
hancer, we postulate the presence of a midbrain-
specifying element, between bases 1068 and 1199 (element
Transgene
positive
CNS
EctopicEntire Midbrain
2 0 0
18 8 0
3 0 3
8 0 2
21 0 9
10 8 0
8 2 0
6 2 0
7 5 0
5 4 0
or rat or human the CNS enhancer (constructs 16 and 20) were
activity. The total number of embryos examined and the number
The midbrain enhancer is not specific at stages earlier or later than
staining at later developmental stages. The striking frequency of
stages provided further evidence for the presence of a general
sue-specific regulatory elements (downregulation of MB enhancer
es was obtained. We obtained 14 ectopically stained embryos of 34
ructs (P , 0.0001).ct 8)
idase
ted.
cific
ental
e tis
ic sitA), and a general transcriptional potentiator element, be-
s of reproduction in any form reserved.
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318 Yaworsky and Kappentween bases 1200 and 1255 (element B), which, in the
absence of the tissue-specific elements, promotes transgene
expression in a nonspecific fashion. In the presence of
FIG. 4. Sequence conservation in the second intron of the rat and
human nestin gene. Sequencing was performed by an ABI automatic
sequencer. (A) Comparison between the two intron sequences was
performed using the Complign program of McMolly Tetra (3.5) with
minimal match length, 10; mismatches, 0; and gap penalty, 3. The
sequences are overall 37% similar with the highest region of similar-
ity clustered in the last third of the intron. (B, C) Sequence alignments
were performed using the Bestfit program of GCG. (B) The sequences
of the midbrain enhancer from rat (upper) and human (lower) are 72%
similar. (C) The CNS-enhancer sequences are 85% similar. Sequence
identities are shaded, and putative transcription factor binding sites
are underlined and labeled. Numbering is identical to the intron
sequences deposited in GenBank under Accession Nos. AF004334
(rat) and AF004335 (human).element A, this potentiator element reproducibly contrib-
Copyright © 1999 by Academic Press. All righttes to transgene expression in the ventral midbrain. In the
NS enhancer, there are likely two sites that must interact
o produce enhancer activity throughout the developing
ervous system. Our data have refined these sites to regions
etween bases 1272 and 1400 (element C) and 1401–1477
element D). Such multiple regulatory elements may be
equired to ensure that CNS progenitor cells express nestin
rrespective of their location along the anterior–posterior or
orsal–ventral axis of the embryo and at appropriate times
uring embryogenesis.
The sequences from both the rat and human nestin gene
econd intron are novel and divergent from each other.
ignificant stretches of similarity are only present in se-
uences that we define as functional enhancers. Potential
ranscription factor binding sites, conserved within the
nhancer elements, may provide insights into the molecu-
ar mechanisms that regulate nestin expression in the
ervous system. In both the midbrain enhancer and the
NS enhancer, we have identified half-sites for potential
XR-b binding (Marks et al., 1992). These half sites may
serve as targets for other members of the nuclear receptor
FIG. 5. Model of neural stem cell heterogeneity. A schematic
representation of a transverse section through the third and fourth
ventricles of a 10.5 dpc embryo is shown. Dorsal is on the right.
Colors indicate cells that activate the midbrain enhancer (A) or the
CNS enhancer (B). C depicts cells that express nestin protein. The
comparison identifies three populations of neuroepithelial cells:
Population 1 is nestin1/CNS enhancer1/MB enhancer1; population
2 is nestin1/CNS enhancer1/MB enhancer2; and population 3 is
1 2nestin /enhancer .
s of reproduction in any form reserved.
s
n
n
e
w
n
e
t
e
t
s
a
d
m
d
fl
n
p
m
T
r
n
s
a
s
t
e
f
s
1
a
e
e
w
a
n
p
n
i
e
r
p
v
e
a
u
m
F
f
t
a
p
t
r
s
f
a
r
n
a
m
t
C
t
p
c
e
r
a
e
v
m
f
a
a
e
p
m
e
t
i
f
w
C
g
l
b
o
t
a
t
p
b
c
a
n
1
319CNS Enhancer Elements in the Nestin Genefamily of transcription factors which bind DNA as a mono-
mer at the RXR core recognition motif (Wilson et al., 1993;
Glass, 1994; Kastner et al., 1995). In the CNS enhancer, we
also identified two binding sites for POU-domain transcrip-
tion factors. The conservation of transcription factor con-
sensus sites together with the expression of these factors in
the developing nervous system (He et al., 1989) provides
trong support for the possibility that POU domain or
uclear receptor proteins may be involved in regulating
estin enhancer activity.
Since nestin is a structural gene, widely expressed during
mbryonic development, the finding of a distinct enhancer
ith activity only in a small subset of ventral midbrain
euroepithelial cells was unexpected. The biological rel-
vance of this regulatory element is presently unclear since
he same midbrain cells can activate the 206-bp CNS
nhancer which lacks bases 1068–1271. However, it is
empting to ascribe a functional role for the midbrain-
pecific enhancer based on both its sequence conservation
nd its activity in neural progenitor cells that give rise to
opaminergic neurons of the ventral mesencephalic teg-
entum (Bayer et al., 1995). Most intriguingly, the RXR-b
consensus motif at base 1154 (rat), with one mismatch,
represents the consensus site for the orphan nuclear recep-
tor, Nurr1 (Law et al., 1992; Murphy et al., 1995). By 10.5
pc, Nurr1 mRNA is detected in the ventral mesencephalic
exure prior to the expression of markers for dopaminergic
eurons, and Nurr1-null mice die early postnatally with
rofound deficits in the midbrain including the loss of
idbrain dopaminergic neurons (Zetterstro¨m et al., 1997).
ogether, these data suggest that Nurr1 may play a role in
egulating the expression of nestin in the midbrain. The
estin midbrain enhancer will be useful to dissect cell
ignaling and transcriptional mechanisms in the midbrain
s well as to direct heterologous gene expression to precur-
ors of dopaminergic cells. Because these neurons are selec-
ively lost in Parkinson’s disease, the nestin midbrain
nhancer provides a novel tool in gene therapy approaches
or treating neurodegenerative diseases.
Nestin has been previously established as a marker for
tem cells of the nervous system (Frederiksen and McKay,
988; Lendahl et al., 1990; Morshead et al., 1994; Reynolds
nd Weiss, 1992; Stemple and Anderson, 1992). These
xperiments documented that nestin is expressed in prolif-
rative cells that can give rise to both neurons and glia as
ell as self renew. Our data show that nestin enhancer
ctivity is always coincident with the known pattern of
estin protein expression (Fig. 3) and that these cells are
roliferative based on immunodetection of proliferating cell
uclear antigen (PCNA, not shown). Thus, enhancer activ-
ty is restricted to neural progenitor cells.
We propose that the differential activity of enhancer
lements in the ventral midbrain and other CNS regions
eveals molecular variations among CNS progenitor cell
opulations. The midbrain enhancer is only active in the
entral midbrain progenitor cells (Fig. 5A), while the CNS
nhancer is active in distinct regions of both the hindbrain m
Copyright © 1999 by Academic Press. All rightnd midbrain (Fig. 5B), and nestin protein is detected almost
niformly throughout the same regions (Fig. 5C). The
idbrain cells that activate both enhancers (population 1,
ig. 5C) must, a priori, possess a pool of transcription
actors different from other CNS cells that can only activate
he CNS-specific enhancer (population 2). In addition, there
re populations of cells (population 3) which express nestin
rotein without activating either nestin enhancer. This
hird population of progenitor cells, too, must differ in its
epertoire of transcription factors. Our model thus defines
ubpopulations of neuroepithelial cells based on their dif-
erences in transcription factor repertoires which may play
role in specifying eventual neuronal fates.
It has recently been proposed that the generation of
egional neuronal diversity is conferred by unique combi-
ations of transcription factor expression in the forebrain
nd anterior neural tube (Rubenstein et al., 1994; Shi-
amura et al., 1995). An intriguing aspect of our study is
hat such transcriptional heterogeneity in the developing
NS is now being detected from the standpoint of a
ranscriptional target. Given that nestin is a structural
rotein that is transiently expressed in most neural stem
ells, the temporal and regional control of specific enhanc-
rs may serve as the paradigm to define the functional
elevance of transcriptional repertoires in CNS stem cells
nd to investigate to which extent cell intrinsic and cell
xtrinsic factors determine the generation of neuronal di-
ersity.
Cell transplantation experiments suggest that environ-
ental influences alone may not be sufficient to account
or neuronal diversity (Campbell et al., 1995; Lumsden et
l., 1994; Suhonen et al., 1996), revealing early cell-
utonomous differences in neural stem cell lineages. How-
ver, there are also examples where transplanted neural
recursors have been shown to adapt to their new environ-
ent (Bru¨stle et al., 1995; Campbell et al., 1995; Renfranz
t al., 1991; Vicario-Abejon et al., 1995). In these models,
he transplanted stem cells were capable of interpreting the
nstructive environmental cues of the ectopic site and
ollow a differentiation pathway characteristic of cells
hich normally reside there. Together these variations in
NS stem cell behavior can likely be explained by hetero-
eneity in neural stem cells with respect to temporal,
ineage, and regional restrictions.
Temporal heterogeneity between neural stem cells has
een well documented for the retina, where the competence
f multipotential progenitor cells to produce specific cell
ypes changes over time (Turner and Cepko, 1987; Wetts
nd Fraser, 1988; Cepko et al., 1996). Analogously, the strict
emporal regulation of the midbrain enhancer implies tem-
oral changes in transcriptional repertoires in ventral mid-
rain progenitor cells. Heterogeneity of neuroepithelial
ells with respect to future neuronal cell lineages is evident
t the molecular level by differential expression of the
eurogenin family of transcription factors (Sommer et al.,
996). Interestingly, except for perhaps the midbrain dopa-
inergic precursor cells, we find no evidence for a correla-
s of reproduction in any form reserved.
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This further supports the notion that nestin enhancers are
activated by progenitor cells prior to cell type specification
or lineage restriction. Finally, it has been shown that
neuronal progenitor cells are nonuniform, based on region.
Diffusible factors from the floor plate and notochord are
capable of inducing ventral cell types (Hynes et al., 1995a;
amada et al., 1993). However, the dopaminergic cells of
he ventral midbrain require contact-mediated interactions
ith the floor plate (Hynes et al., 1995b). These data imply
that ventral neuronal progenitor cells vary in response to
floor plate inductive signals in a region-specific manner.
Our identification of a midbrain-specific enhancer provides
evidence that ventral midbrain cells also possess transcrip-
tional competence distinct from cells in other ventral
regions of the developing CNS.
Therefore, while nestin protein expression has previously
been thought to be a general marker of neural stem cells,
the distinct regulatory mechanisms for nestin enhancer
activation provide compelling evidence for molecular het-
erogeneity of developing CNS cells. These molecular differ-
ences in neural progenitor cells may be functionally rel-
evant in the eventual specification of neuronal subtype.
Distinct populations of progenitor cells can now be identi-
fied and isolated by virtue of nestin enhancer activity.
These enhancers and the future identification of specific
transcription factors will have important implications for
the development of stem cell transplantation strategies in
neurodegenerative diseases.
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